Vanderbilt University School of Medicine, Nashville, Tennessee.
Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
J Surg Res. 2023 May;285:197-204. doi: 10.1016/j.jss.2022.12.026. Epub 2023 Jan 23.
Lymphangiomas are rare, cystic tumors that represent congenital malformation of the lymphatic vessels. We reviewed our institution's experience treating abdominal lymphangiomas with the purpose of describing the clinical features, management, and outcomes of this rare pathology.
This is a single-institution, institutional review board-approved retrospective review of abdominal lymphangiomas presenting between January 2010 and February 2021. The diagnosis of lymphangioma was made on histopathology from either endoscopic or excisional biopsy of the lesion. Demographics, diagnostic imaging, histopathologic characteristics, and outcomes were analyzed.
We identified 48 patients, of whom 29 (60%) were female, >18 y (38; 79%), with a mean age of 43 y at the time of diagnosis (range, 4 d-87 y). Tumors ranged in size from <1 cm to 30 cm. Only 1/3 were symptomatic, most commonly with abdominal pain (9; 19%) On preoperative imaging, mural nodules or thickened walls were present in one case, in which pathology was consistent with benign lymphangioma. The majority of lymphangiomas were associated with the small bowel or its mesentery (31; 65%), followed by the colon/omentum (7; 15%). Most patients underwent surgical excision (29; 60%) with incomplete excision in one patient due to extensive local invasion, and three (10%) patients required multivisceral resection. The median duration of the follow-up was 13 mo (range, 1-105 mo), during which time, none of the patients developed malignancy.
Most abdominal lymphangiomas arise from the small bowel and are found incidentally and have a favorable prognosis. Resection should be reserved for symptomatic lesions or when there is a diagnostic uncertainty.
淋巴管瘤是一种罕见的囊性肿瘤,代表淋巴管的先天性畸形。我们回顾了我们机构治疗腹部淋巴管瘤的经验,旨在描述这种罕见病理的临床特征、治疗方法和结果。
这是一项单机构、机构审查委员会批准的回顾性研究,纳入了 2010 年 1 月至 2021 年 2 月期间就诊的腹部淋巴管瘤患者。淋巴管瘤的诊断是基于病变的内镜或切除活检的组织病理学。分析了人口统计学、诊断影像学、组织病理学特征和结果。
我们共确定了 48 例患者,其中 29 例(60%)为女性,年龄>18 岁(38 例;79%),诊断时的平均年龄为 43 岁(范围为 4 天-87 岁)。肿瘤大小从<1cm 到 30cm 不等。仅有 1/3 的患者有症状,最常见的症状是腹痛(9 例;19%)。术前影像学检查显示,1 例存在壁结节或增厚壁,其病理结果符合良性淋巴管瘤。大多数淋巴管瘤与小肠或其肠系膜相关(31 例;65%),其次是结肠/大网膜(7 例;15%)。大多数患者接受了手术切除(29 例;60%),其中 1 例由于广泛局部侵犯未能完全切除,3 例(10%)患者需要多脏器切除。中位随访时间为 13 个月(范围为 1-105 个月),在此期间,没有患者发生恶性肿瘤。
大多数腹部淋巴管瘤起源于小肠,多为偶然发现,预后良好。对于有症状的病变或存在诊断不确定性的病变,应保留切除治疗。